Viatom Offers Several FDA-Cleared Pulse Oximeters| Sleep Review

Oct 15, 2024 | Screeners | 0 |

The US Food and Drug Administration has cleared several of Shenzhen, China-based Viatom Technology Co Ltd’s pulse oximeters. These pulse oximeters include the Oxyfit and the Checkme O2.

The Oxyfit is a noninvasive device intended for spot checking and/or continuous data collection of functional oxygen saturation of arterial hemoglobin and pulse rate. This portable fingertip-worn pulse oximeter by Viatom is indicated for use in adult patients in home environments and clinical institutions except in acute clinical environments.

According to Viatom, the Oxyfit pulse oximeter features a soft, hypoallergenic silicone duck-bill sensor, 4-session recordings (each session of 1 hour SpO2, pulse rate, perfusion index, and motion data storage), real-time Bluetooth data transfer, and customizable alerts for abnormalities. The built-in rechargeable battery lasts up to 14 hours continuously.

Viatom’s Checkme O2 is a wrist pulse oximeter indicated for use in measuring, displaying, storing and transmitting functional oxygen saturation of arterial hemoglobin and pulse rate for adult patients. It is intended for spot-check and/ or continuous data collection, and not continuous monitoring. It can be used in sleep labs, long-term care, hospitals and home use.

According to Viatom,the Checkme O2 has up to a 10-hour memory for one recording, a free smartphone app for real-time tracking, and is Ideal for sleep testing, sleep apnea prescreening and hypoxia management, and continuous health monitoring.

Share:

Rate: